(BPAX) Mcap 55 M /Cash 70 M /FDA DECISION 14 FEB 2012

[BiotechMaster]

This Goldmine currently trades below cash but this will change with the upcoming FDA Decision on 14th Feb . FDA approval will push this wayyy oversold goldmine back to $2++ easily ..

Buy now and make a lot of money with the runup to Fda decision folks .

TARGET 3-5 dollar in 2012 ! GLTA


Biosante (BPAX)

Market cap : $56 M
Cash : $ 70 M

Price: 0.515



MEGA PIPELINE
BioSante Pharmaceuticals - Products



Bio-T-Gel™

Bio-T-Gel™ is a once-daily transdermal testosterone gel in development for the treatment of male hypogonadism, or low testosterone levels. Male hypogonadism generally is characterized by impotence, a lack of sex drive, muscle weakness and osteoporosis. In 2010, the transdermal testosterone market for men in the U.S. was over $1.2 billion.

Bio-T-Gel™ is licensed to Teva Pharmaceuticals, USA. A Bio-T-Gel™ NDA is pending with the FDA having a PDUFA date of February 14, 2012. Teva is responsible for all regulatory and marketing activities.

[BiotechMaster]

More infos about this massive undervalued Company ..... GLTA

MONSTER PIPELINE :

Part 1
BioSante Pharmaceuticals - Products

Part 2
http://www.biosantepharma.com/images/gvax-imm-chart.gif

BPAX has equity stake in external companies :

BPAX has 16% Stake in Ceregene
Ceregene - Pipeline

BPAX has 19.9% Stake in Coldgenesys
Cold Genesys Inc - **** * ** * * ** * * ** * * * * * * * * * * * * ** Products


Institutions bought the **** out of it since the drop in December and now the Institutions holding more than 45 Mil shares thats the highest level in the of this Company
Institutional Investment in BPAX: Biosante Pharmaceuticals Inc


Management bought most of their shares above $1.50 and they never sold a single share .
BPAX Insider Trading - Biosante Pharmaceuticals Inc - Form 4 SEC Filings

[Lucifer]

Mega volatility for this stock recently
Down 10% once day, up 8% another
Traders' chew toy for sure

[giasone]

Bio t-Gel - Approved !